Beschrijving
Product Properties
|
Property Name |
Property Details |
|
Alternative Names |
CGM1, CD66d, CEACAM3 |
|
Species |
Human |
|
Expression Sequence |
Lys35-Gly155 |
|
Accession |
P40198-1 |
|
Tag |
C-hFc |
|
Expression System |
HEK293 |
|
Molecular Weight |
The protein has a predicted MW of 39.85 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on SDS-PAGE result. |
|
Purity |
>95% as determined by SDS-PAGE and HPLC. |
|
Endotoxin |
<1.0 EU per μg by the LAL method. |
|
Formulation |
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
|
Appearance |
Lyophilized Powder |
|
Biological Activity |
【ELISA Data】Immobilized Human CEACAM-7, His Tag at 1μg/mL (100μL/well) on the plate. Dose response curve for Human CEACAM-3, hFc Tag with the EC₅₀ of 31.1ng/mL determined by ELISA. |
|
Reconstitution Method |
Before opening, centrifuge briefly. Reconstitute the lyophilized protein with distilled water to a concentration exceeding 100 μg/mL. Aliquot after initial reconstitution to avoid repeated freeze-thaw cycles. |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Lyophilized powder: Store at -25 to -15°C; stable for 1 year upon receipt.
Reconstituted protein: Store under sterile conditions at -85 to -65°C; stable for 3 months.
Betaling en beveiliging
Uw betalingsinformatie wordt veilig verwerkt. We slaan geen creditcardgegevens op en hebben geen toegang tot uw creditcardinformatie.
Navraag
Misschien vind je het ook leuk
FAQ
Het product is alleen bedoeld voor onderzoeksdoeleinden en is niet bedoeld voor therapeutisch of diagnostisch gebruik bij mensen of dieren. Producten en inhoud worden beschermd door patenten, handelsmerken en auteursrechten die eigendom zijn van
Voor bepaalde toepassingen zijn mogelijk aanvullende intellectuele eigendomsrechten van derden vereist.